148 related articles for article (PubMed ID: 37453866)
41. The Changing Landscape of Lymphoma Associated with HIV Infection.
Hübel K
Curr Oncol Rep; 2020 Aug; 22(11):111. PubMed ID: 32803474
[TBL] [Abstract][Full Text] [Related]
42. Non-Hodgkin's Plasmablastic Lymphoma as Initial Presentation of Human Immunodeficiency Virus.
Jariwal R; Raza N; Bhandohal J; Cobos E
J Investig Med High Impact Case Rep; 2021; 9():23247096211014689. PubMed ID: 33980062
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous plasmablastic lymphoma.
Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
[TBL] [Abstract][Full Text] [Related]
44. [Human immunodeficiency virus and lymphoma].
Tazi I; Lahlimi FZ
Bull Cancer; 2021 Oct; 108(10):953-962. PubMed ID: 34246454
[TBL] [Abstract][Full Text] [Related]
45. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
46. Plasmablastic lymphoma involving the stomach in an HIV positive man.
Angeleri A; Rocher AE; Myburg C; Avagnina A; Aparo V; Palaoro LA
Cytopathology; 2016 Aug; 27(4):293-5. PubMed ID: 26899982
[No Abstract] [Full Text] [Related]
47. Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal.
Sanguedolce F; Zanelli M; Zizzo M; Martino G; Rossi C; Parente P; Ascani S
Pathol Res Pract; 2020 Jun; 216(6):152973. PubMed ID: 32370987
[TBL] [Abstract][Full Text] [Related]
48. Human Immunodeficiency Virus Associated Plasmablastic Lymphoma Involving Bones and Peritoneum in a 4-Year-old Child.
Ramanathan S; Moulik NR; Dhamne C; Shah S; Shet T; Narula G
J Pediatr Hematol Oncol; 2023 May; 45(4):213-215. PubMed ID: 35973102
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal Tract Plasmablastic Lymphoma in HIV-Infected Adults: A Histopathological Review.
Mwazha A; Nhlonzi GB; Mazengenya P
Int J Surg Pathol; 2020 Oct; 28(7):735-748. PubMed ID: 32552168
[TBL] [Abstract][Full Text] [Related]
50. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.
Courville EL; Yohe S; Chou D; Nardi V; Lazaryan A; Thakral B; Nelson AC; Ferry JA; Sohani AR
Mod Pathol; 2016 Oct; 29(10):1200-11. PubMed ID: 27443517
[TBL] [Abstract][Full Text] [Related]
51. Pediatric plasmablastic lymphoma: Diagnostic and therapeutic dilemma.
Misra A; Bakhshi S; Kumar R; Chopra A
Indian J Pathol Microbiol; 2017; 60(2):303-304. PubMed ID: 28631667
[No Abstract] [Full Text] [Related]
52. Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
Pinnix CC; Shah JJ; Chuang H; Costelloe CM; Medeiros LJ; Wogan CF; Reed V; Smith GL; Milgrom S; Patel K; Huo J; Turturro F; Romaguera J; Fayad L; Oki Y; Fanale MA; Westin J; Nastoupil L; Hagemeister FB; Rodriguez A; Qazilbash M; Shah N; Bashir Q; Ahmed S; Nieto Y; Hosing C; Rohren E; Dabaja B
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):122-8. PubMed ID: 26795083
[TBL] [Abstract][Full Text] [Related]
53. Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion.
Yoshihara K; Yoshihara S; Matsuda I; Imado T; Matsuo S; Okada M; Shimizu Y; Hirota S; Fujimori Y
Ann Hematol; 2020 Jun; 99(6):1405-1407. PubMed ID: 32125468
[No Abstract] [Full Text] [Related]
54. Lymphoid neoplasms of the oral cavity with plasmablastic morphology-a case series and review of the literature.
Bhattacharyya S; Bains APS; Sykes DL; Iverson BR; Sibgatullah R; Kuklani RM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Dec; 128(6):651-659. PubMed ID: 31494113
[TBL] [Abstract][Full Text] [Related]
55. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT.
Makis W; Ciarallo A; Lisbona R
Acta Radiol; 2011 Nov; 52(9):970-2. PubMed ID: 21911839
[TBL] [Abstract][Full Text] [Related]
56. Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.
Sabry W; Wu Y; Kodad SG
Curr Oncol; 2022 Jul; 29(7):5042-5053. PubMed ID: 35877259
[TBL] [Abstract][Full Text] [Related]
57. Unilateral Maxillary Sinus Plasmablastic Lymphoma in an Immunocompetent Patient. An Unusual Occurrence Report and Literature Review.
Chicuellar NR; Sufyan W; Mahendran S
Ear Nose Throat J; 2022 Jul; 101(6):NP251-NP255. PubMed ID: 33044847
[TBL] [Abstract][Full Text] [Related]
58. Primary Maxillary Sinus Plasmablastic Lymphoma in HIV/AIDS.
Basavaraj A; Kadam M; Kadam DB
J Assoc Physicians India; 2016 May; 64(5):71-72. PubMed ID: 27735156
[TBL] [Abstract][Full Text] [Related]
59. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
60. Plasmablastic lymphoma: a systematic review.
Castillo JJ; Reagan JL
ScientificWorldJournal; 2011 Mar; 11():687-96. PubMed ID: 21442146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
